A Phase 1, Open-Label, Multiple Ascending Dose, [18F]MNI-659 PET-Imaging Study to Evaluate PDE10A Occupancy After Dosing With EVP-6308 in Healthy Subjects

Trial Profile

A Phase 1, Open-Label, Multiple Ascending Dose, [18F]MNI-659 PET-Imaging Study to Evaluate PDE10A Occupancy After Dosing With EVP-6308 in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Oct 2014

At a glance

  • Drugs FRM 6308 (Primary)
  • Indications Schizophrenia
  • Focus Pharmacokinetics
  • Sponsors FORUM Pharmaceuticals
  • Most Recent Events

    • 09 Oct 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov
    • 09 Dec 2013 Status changed from planning to recruiting, as reported by ClinicalTrials.gov record record.
    • 09 Dec 2013 New source identified and integrated: ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top